Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022116 (
ischemia
)
91,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Forty-two nonhypertensive patients with a proven
subarachnoid hemorrhage
but normal cerebral panangiography were in vestigated. The follow-up period was 1 to 5 years, with a mean of 39.1 months. Treatment consisted of 2 weeks of bedrest and sedation, followed by progressive mobilization on the 3rd week. Thirteen patients (Group A) were treated with tranexamic acid, whereas 29 patients (Group B) received no antifibrinolytic therapy. Five patients Of Group A died of
ischemia
caused by cerebral vasospasm. No patient of Group B died, and there was no early rebleeding in either group. Therefore, antifibrinolytic therapy is not indicated in these patients. Only 1 of 42 patients (2.4%) experienced late rebleeding, and he again had normal cerebral panangiography. Reangiography several weeks or months after the first hemorrhage seems not to be indicated. The overall prognosis of the surviving patients was good; almost all were able to return to their previous occupations within 6 months after the hemorrhage.
...
PMID:Subarachnoid hemorrhage with normal cerebral panangiography. 663 33
The presence of lactic acidosis in the cerebrospinal fluid of patients suffering brain injury as the result of trauma,
subarachnoid hemorrhage
, neoplasia, or
ischemia
has been well documented. The authors theorized that this acidosis becomes harmful in itself, and that treatment with an alkalinizing agent (tris(hydroxymethyl)aminomethane: tromethamine) capable of penetrating the blood-brain barrier would be efficacious. Fifteen pairs of mongrel cats were subjected to a 2.85-atmosphere fluid-percussion injury (LD80), and were supported by respirators for up to 72 hours prior to being placed in cages for an additional 4 days of observation. Experimental cats underwent continuous infusion of tromethamine (begun 10 minutes after injury); control animals were infused with an equal volume of lactated Ringer's solution. Twenty percent of the control group survived until sacrificed on Day 7 post-injury. Survival in the tromethamine group was 60% (p less than 0.05), and morbidity also appeared to be reduced in the treated cats. Intracranial pressure (ICP) in treated cats was 60% (p less than 0.05) of that in the control cats after respirator support for 3 days. Tromethamine infusion was associated with improved survival, decreased morbidity, and decreased ICP when compared with results in control animals. The literature with regard to central nervous system acidosis has been reviewed in an attempt to clarify and define this problem.
...
PMID:Experimental brain injury: successful therapy with the weak base, tromethamine. With an overview of CNS acidosis. 671 65
This study concerns 74 patients with
subarachnoid haemorrhage
from ruptured supratentorial aneurysm--Serial electroencephalographic recordings (EEG) have been made with precise chronology. The first EEG (Day 1 or 2) had a prognostic value, good if it was normal, alarming if axial bursts or comatose patterns were recorded. Associated with CT scan and dosage of Fibrin degradation products in C.S.F. (F.D.P.), initial EEG gave a strong probability in predicting the occurrence of secondary
ischemia
. The second EEG, between Day 4 and Day 7, had a diagnostic value. When a vasospasm occurred, confirmed by further angiography, focal or unilateralized slow waves were recorded in more than 85% or these EEG. Further EEG gave the opportunity of controlling the evolution of ischemic electrical patterns.
...
PMID:[Contribution of the electroencephalogram to the diagnosis of vasospasm after rupture of intracranial aneurysms]. 671 12
Antifibrinolytic therapy remains a controversial issue in the management of
subarachnoid hemorrhage
(
SAH
). The relationship of antifibrinolytic therapy with mortality, rebleeding,
ischemia
, hydrocephalus, and clotting abnormalities was studied in 672 patients in the International Cooperative Study on the Timing of Aneurysm Surgery. The patients with antifibrinolytic therapy had a significantly lower rebleeding rate, but higher rates of ischemic deficits and hydrocephalus. The net result was no difference in mortality in the 1st month following the initial
SAH
. Further clinical trials are needed to determine the overall effects of antifibrinolytic therapy.
...
PMID:Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study. 673 46
Data from 722 consecutive causes with intracranial aneurysms were stored in a computer and later retrieved for analysis. Results and complications (including preoperative death and morbidity) of the surgical management of these patients were correlated with the Botterell grade of the patient in individuals with a recent
subarachnoid hemorrhage
(
SAH
), with the type of aneurysm, and with the timing of the surgical procedure. Patients with no
SAH
within 30 days prior to hospital admission were classified as "no
SAH
." Approximately 30% of all patients had sustained more than one hemorrhage. Death and morbidity rates prior to surgery in good-grade patients with a recent
SAH
exceeded the risk of surgery itself. Rebleeding was the primary cause for death and morbidity in Grade 1 patients: 3% of Grade 1 patients died from a recurrent hemorrhage and 7% deteriorated to a lower grade. Deterioration from
ischemia
produced by vasospasm related or unrelated to rebleeding exceeded the risks of rebleeding in Grade 2 patients. There was an operative morbidity of 2% and mortality of 2% in patients who were classified as Grade 1 at the time of surgery, but an overall management morbidity of 3% and mortality of 6% in patients who were in Grade 1 at the time of hospital admission. Early surgery in Grade 1 patients was not associated with an increased incidence of delayed
ischemia
postoperatively. In Grade 2 patients, the operative morbidity and mortality was 7% and 4%, respectively, and the management morbidity and mortality 16% and 11%, respectively. Early surgery in this group was associated with a high frequency of postoperative delayed
ischemia
(particularly in patients with more than one
SAH
). Epsilon-aminocaproic acid appeared to protect against a rebleed, gut was associated with a higher incidence of postoperative pulmonary emboli. Intraoperative complications were related both to the size of the aneurysm and to its location. Repair of multiple aneurysms did not adversely affect the result. The surgical approach, the importance of using a self-retaining brain retractor, and the technical complications in these cases are discussed.
...
PMID:Results and complications of surgical management of 809 intracranial aneurysms in 722 cases. Related and unrelated to grade of patient, type of aneurysm, and timing of surgery. 680 8
An unusual case of delayed
ischemia
following rupture of an aneurysm of the left internal carotid artery is reported. Symptoms occurred twice after clipping the aneurysm and removing most of the subarachnoid blood on the left side the day after
subarachnoid hemorrhage
(
SAH
). Initial
ischemia
due to vasospasm occurred on the left side of the brain on the 8th day after
SAH
and responded favorably to induced hypervolemia. After complete recovery, a second episode due to vasospasm occurred on the 16th day after
SAH
on the right side of the brain from which the subarachnoid blood had not been removed. This caused a massive lesion and permanent severe neurological deficits. This case suggests that removal of subarachnoid blood may affect the severity and time course of vasospasm, and emphasizes the necessity of extensive removal of subarachnoid blood for prevention of severe delayed ischemic symptoms.
...
PMID:Biphasic occurrence of delayed ischemia after early aneurysm surgery. Case report. 682 35
26 patients with
subarachnoid hemorrhage
from ruptured cerebral aneurysms have been reviewed. Fibrinolytic activity of the C.S.F. has been evaluated by the dosage of Fibrin/Fibrinogen degradation products (F.D.P.). When patients have developed clinical signs of
ischemia
, F.D.P. levels were significantly higher than in those without neurological deficit. Even, if the detection of F.D.P. seems directly correlated to the presence of blood in the C.S.F., there is no direct relation between their level and the importance of S.A.H. as shown by C.T. scan. However when F.D.P. levels are greater than 80 mcg/ml, there is a high risk of vasospasm with clinical signs.
...
PMID:[Prognostic value of cerebrospinal fluid fibrinolytic activity in meningeal hemorrhages as a result of aneurysm rupture]. 688 30
High dose barbiturates were used to treat intracranial hypertension in 15 patients with nontraumatic brain lesions; (3 hypertensive hemorrhage, 4
subarachnoid hemorrhage
, 5 infarction, 2 global anoxia-
ischemia
and 2 encephalitis). All had persistently raised intracranial pressure (ICP) while being treated with aggressive conventional therapy. The addition of barbiturates caused an initial lowering of ICP in 11 patients, but only 5 of these had sustained ICP reductions. Survival of the 5 patients with persistently lowered ICP and death of the remaining 10 may indicate an improvement in outcome attributable to the addition of high dose barbiturates to conventional therapy in non-traumatic brain swelling. Because of the resources required for their prolonged use, randomized studied in patients with intracranial hypertension are required to determine the effect of barbiturates on outcome.
...
PMID:High dose barbiturates in non-traumatic brain swelling: ICP reduction and effect on outcome. 714 92
We conducted serial neurologic examinations on 500 patients in nontraumatic coma to identify factors predicting recovery. Overall, 81 patients (16%) led an independent life at some point within the first year; the remainder either died without recovery from coma (61%), never improved beyond the vegetative state (12%), or regained consciousness but remained dependent on others for daily activities (11%). Functional recovery did not depend on age but was to some degree related to the cause of coma (
subarachnoid hemorrhage
and other cerebrovascular disease having the worst recovery; hypoxia-
ischemia
, intermediate; and hepatic and miscellaneous causes, best) and especially to early clinical signs of brain dysfunction. Even within hours of the onset of coma, only one of 120 patients lacking two of corneal, pupillary, and oculovestibular responses ever regained independent function. The study identifies clinical features of comatose patients that appear within the first week and that are important for predicting recovery and designing future therapeutic trials.
...
PMID:Prognosis in nontraumatic coma. 722 76
A case of
subarachnoid hemorrhage
(
SAH
) complicating cerebral arterial ectasia is reported. While
ischemia
and cranial nerve palsies are commonly associated with this condition, review of the literature reveals that
SAH
is exceedingly rare. The pathogenesis, radiographic findings, and clinical complications of cerebral arterial ectasia are discussed.
...
PMID:Recurrent subarachnoid hemorrhage complicating cerebral arterial ectasia. Case report. 724 Dec 5
<< Previous
1
2
3
4
5
6
7
8
9
10